Purpose Mindfulness-based stress reduction (MBSR) is a standardized meditation program that may be an effective therapy for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), a condition exacerbated by stress. The aims of this study were to explore 1) whether MBSR improved IC/BPS symptoms 2) MBSR’s feasibility/acceptability among women with IC/BPS. Materials and Methods This randomized controlled trial included women with IC/BPS undergoing 1st-or 2nd line therapies. Women were randomized to continuation of usual care (UC) or an 8-week MBSR class + usual care (MBSR). Participants completed baseline and 8 week post-treatment questionnaires including the O’Leary-Sant Symptom Problem Index (OSPI), visual analog pain scale (VAS), Short Form Health Survey (SF-12), Female Sexual Function Index (FSFI), and Pain Self-Efficacy Questionnaire (PSEQ). The Global Response Assessment (GRA) was completed post-treatment. Analyses were performed using Student’s t-test, Chi-square and MANOVA where appropriate. Results Eleven women randomized to UC and 9 to MBSR, without differences in group characteristics. More MBSR participants’ symptoms were improved on the GRA [7/8(87.5%) vs. 4/11(36.4%), p=0.03]. The MBSR group had greater improvement in OSPI total (p=0.0498) and problem scores (p=0.036); OSPI symptom score change did not differ. PSEQ scores improved in MBSR compared to UC (p=0.035). VAS, SF-12, and FSFI change did not differ between groups. Eighty-six percent of MBSR participants felt more empowered to control symptoms, and all participants planned to continue MBSR. Conclusions This trial provides initial evidence that MBSR is a promising adjunctive therapy for IC/BPS. Its benefit may arise from patients’ empowerment and ability to cope with symptoms.

Purpose-Mindfulness-based stress reduction (MBSR) is a standardized meditation program that may be an effective therapy for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), a condition exacerbated by stress. The aims of this study were to explore 1) whether MBSR improved IC/BPS symptoms 2) MBSR's feasibility/acceptability among women with IC/BPS. Results-Eleven women randomized to UC and 9 to MBSR, without differences in group characteristics. More MBSR participants' symptoms were improved on the GRA [7/8(87.5%) vs. Materials and Methods-This

the published abstract book. We excluded all nonphysicians and anyone from outside the United States. We collected financial conflicts using the CMS Open Payments database from 2014 (http://www.cms.gov/openpayments). Company names, number of transactions, amount paid, and payment types were recorded. Companies listed for each individual in CMS were compared to abstract book disclosures to determine the disclosure rate. For individuals with more than one abstract, disclosures were summed across abstracts and compared in total to the CMS report and checked for concordance. Two authors reviewed each nondisclosed CMS listing to determine whether the company and its product line were related to the content of the abstract. Listing was deemed relevant if consensus was reached between the two reviewers. RESULTS: The abstracts and disclosures of 335 individuals meeting inclusion criteria were reviewed. Board members without abstracts did not have separate conflict of interest disclosures listed. Two hundred nine of 335 (62%) individuals had financial transactions reported in CMS. Twenty-four of 335 (7.2%) individuals listed specific companies with their abstracts; 5 of those 24 authors accurately included all of their companies listed in CMS. The total amount of money from CMS transactions equaled $1.98 million: 71.6% labeled "general transactions," 28.3% "research transactions," and 0.1% "investments." The total of all non-disclosed transactions equaled $1.3 million. The range of money associated with a single individual was from $11.72 to $405,903.36. One hundred twentytwo companies were listed as having financial ties with authors in CMS, ranging from 1 to 22 companies per individual. Medtronic (33.5%), American Medical Systems Inc. (30%), and Astellas Pharma Inc. (29%) were the companies most often affiliated with individuals in CMS. Of the 187 without any abstract disclosures but with CMS transactions, the majority (65%) had at least one company listed in CMS that was determined to be related to the subject of their abstract. CONCLUSION: Voluntary disclosure of financial relationships with publicly traded companies was poor, and the majority of unlisted disclosures in the abstract book were companies related to the subject of the abstract. Part of this discrepancy may be due to physicians' unfamiliarity of what is reported to CMS. Regardless, better transparency is needed by individuals responsible for the content presented at scientific meetings.OBJECTIVES: To compare differences in pain perception and satisfaction with pain control in women receiving either intravenous ibuprofen or intravenous ketorolac after urogynecologic surgery. MATERIALS AND METHODS: This was a prospective randomized controlled trial including patients undergoing surgery in the division of Female Pelvic Medicine and Reconstructive Surgery between September 2013 and April 2015. After surgery, all patients were randomized to either the ibuprofen or ketorolac groups. Patients were placed on a patient controlled analgesia (PCA) of hydromorphone w...